Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1964 3
1965 2
1966 2
1968 2
1969 3
1970 6
1971 1
1972 3
1973 6
1974 4
1975 11
1976 9
1977 10
1978 18
1979 25
1980 28
1981 17
1982 25
1983 33
1984 29
1985 41
1986 33
1987 31
1988 31
1989 35
1990 41
1991 40
1992 43
1993 41
1994 59
1995 43
1996 50
1997 58
1998 59
1999 67
2000 73
2001 84
2002 72
2003 85
2004 67
2005 99
2006 102
2007 104
2008 90
2009 110
2010 131
2011 118
2012 146
2013 140
2014 142
2015 161
2016 169
2017 174
2018 198
2019 203
2020 218
2021 199
2022 146
2023 119
2024 32

Text availability

Article attribute

Article type

Publication date

Search Results

3,692 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Functioning pituitary gland neoplasm"
Page 1
Clinical and Pathological Aspects of Silent Pituitary Adenomas.
Drummond J, Roncaroli F, Grossman AB, Korbonits M. Drummond J, et al. J Clin Endocrinol Metab. 2019 Jul 1;104(7):2473-2489. doi: 10.1210/jc.2018-00688. J Clin Endocrinol Metab. 2019. PMID: 30020466 Free PMC article. Review.
CONTEXT: Silent pituitary adenomas are anterior pituitary tumors with hormone synthesis but without signs or symptoms of hormone hypersecretion. ...All titles and abstracts of the retrieved articles were reviewed, and recent advances in the field of silent pituit …
CONTEXT: Silent pituitary adenomas are anterior pituitary tumors with hormone synthesis but without signs or symptoms of hormo …
Pangenomic Classification of Pituitary Neuroendocrine Tumors.
Neou M, Villa C, Armignacco R, Jouinot A, Raffin-Sanson ML, Septier A, Letourneur F, Diry S, Diedisheim M, Izac B, Gaspar C, Perlemoine K, Verjus V, Bernier M, Boulin A, Emile JF, Bertagna X, Jaffrezic F, Laloe D, Baussart B, Bertherat J, Gaillard S, Assié G. Neou M, et al. Cancer Cell. 2020 Jan 13;37(1):123-134.e5. doi: 10.1016/j.ccell.2019.11.002. Epub 2019 Dec 26. Cancer Cell. 2020. PMID: 31883967 Free article.
Pituitary neuroendocrine tumors (PitNETs) are common, with five main histological subtypes: lactotroph, somatotroph, and thyrotroph (POU1F1/PIT1 lineage); corticotroph (TBX19/TPIT lineage); and gonadotroph (NR5A1/SF1 lineage). ...
Pituitary neuroendocrine tumors (PitNETs) are common, with five main histological subtypes: lactotroph, somatotroph, and thyrotroph ( …
Single-cell sequencing identifies differentiation-related markers for molecular classification and recurrence prediction of PitNET.
Zhang Q, Yao B, Long X, Chen Z, He M, Wu Y, Qiao N, Ma Z, Ye Z, Zhang Y, Yao S, Wang Y, Cheng H, Chen H, Ye H, Wang Y, Li Y, Chen J, Zhang Z, Guo F, Zhao Y. Zhang Q, et al. Cell Rep Med. 2023 Feb 21;4(2):100934. doi: 10.1016/j.xcrm.2023.100934. Epub 2023 Feb 7. Cell Rep Med. 2023. PMID: 36754052 Free PMC article.
Pituitary neuroendocrine tumor (PitNET) is one of the most common intracranial tumors with variable recurrence rate. Currently, the recurrence prediction is unsatisfying and can be improved by understanding the cellular origins and differentiation status. ...
Pituitary neuroendocrine tumor (PitNET) is one of the most common intracranial tumors with variable recurrence rate. Currently, the r …
Pituitary incidentaloma: an endocrine society clinical practice guideline.
Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM, Post KD, Vance ML; Endocrine Society. Freda PU, et al. J Clin Endocrinol Metab. 2011 Apr;96(4):894-904. doi: 10.1210/jc.2010-1048. J Clin Endocrinol Metab. 2011. PMID: 21474686 Free PMC article.
OBJECTIVE: The aim was to formulate practice guidelines for endocrine evaluation and treatment of pituitary incidentalomas. CONSENSUS PROCESS: Consensus was guided by systematic reviews of evidence and discussions through a series of conference calls and e-mails and one in …
OBJECTIVE: The aim was to formulate practice guidelines for endocrine evaluation and treatment of pituitary incidentalomas. CONSENSUS …
Craniopharyngiomas.
Hamblin R, Tsermoulas G, Karavitaki N. Hamblin R, et al. Presse Med. 2021 Dec;50(4):104078. doi: 10.1016/j.lpm.2021.104078. Epub 2021 Oct 22. Presse Med. 2021. PMID: 34688870 Review.
Whilst classed as histologically benign tumours, their unpredictable growth pattern and proximity to vital structures including the optic chiasm, hypothalamus, and pituitary gland renders them a considerable threat, with significant associated morbidity and increase …
Whilst classed as histologically benign tumours, their unpredictable growth pattern and proximity to vital structures including the optic ch …
Childhood-onset Craniopharyngioma.
Otte A, Müller HL. Otte A, et al. J Clin Endocrinol Metab. 2021 Sep 27;106(10):e3820-e3836. doi: 10.1210/clinem/dgab397. J Clin Endocrinol Metab. 2021. PMID: 34086900 Review.
In the further course of the disease, recurrences and progression often occur. Nevertheless, overall survival rates are high at 92%. ...The search terms used were "craniopharyngioma, hypothalamus, pituitary obesity, irradiation, neurosurgery....
In the further course of the disease, recurrences and progression often occur. Nevertheless, overall survival rates are high at 92%. …
Clinically non-functioning pituitary adenomas.
Chanson P, Wolf P. Chanson P, et al. Presse Med. 2021 Dec;50(4):104086. doi: 10.1016/j.lpm.2021.104086. Epub 2021 Oct 28. Presse Med. 2021. PMID: 34718111 Review.
Clinically non functioning pituitary adenomas (NFPAs) include all pituitary adenomas that are not hormonally active. ...NFPA can sometimes recur even after complete resection, but predicting the individual risk of tumor remnant progression is difficult …
Clinically non functioning pituitary adenomas (NFPAs) include all pituitary adenomas that are not hormonally active. .. …
Pituitary carcinomas.
Colao A, Ochoa AS, Auriemma RS, Faggiano A, Pivonello R, Lombardi G. Colao A, et al. Front Horm Res. 2010;38:94-108. doi: 10.1159/000318499. Epub 2010 Jul 5. Front Horm Res. 2010. PMID: 20616500 Review.
Pituitary carcinoma is a extremely rare and is characterized by a very poor prognosis. ...Recent studies have partially clarified its molecular pathogenesis and found possible markers of aggressiveness in order to make an earlier diagnosis, when still treatment coul …
Pituitary carcinoma is a extremely rare and is characterized by a very poor prognosis. ...Recent studies have partially clarif …
Silent corticotroph adenomas.
Ben-Shlomo A, Cooper O. Ben-Shlomo A, et al. Pituitary. 2018 Apr;21(2):183-193. doi: 10.1007/s11102-018-0864-8. Pituitary. 2018. PMID: 29344907 Review.
PURPOSE: Silent corticotroph adenomas (SCAs) present clinically as non-functioning adenomas (NFAs) but are immunopositive for adrenocorticotrophic hormone (ACTH) without biochemical and clinical manifestation of hypercortisolism. ...CONCLUSION: This article reviews the inc …
PURPOSE: Silent corticotroph adenomas (SCAs) present clinically as non-functioning adenomas (NFAs) but are immunopositive for adrenoc …
3,692 results